CLOV vs RNXT
Clover Health Investments Corp (CLOV) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
CLOV currently screens at market cap $1.55B. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the CLOV and RNXT stock pages for the full models.
Not investment advice.